A review of ageing and an examination of clinical methods in the assessment of ageing skin. Part I: Cellular and molecular perspectives of skin ageing

International Journal of Cosmetic Science

Volumn 30, Issue 5, 2008, Pages 313-322

  Callaghan, T M ^a,b   Wilhelm, K P ^a  

^a proDERM Institute for Applied Dermatological Research   (Germany)

^b Witts Park 16   (Germany)

Author keywords

Molecular skin ageing; Oxidative stress; ROS

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; ELASTIN; REACTIVE OXYGEN METABOLITE;

AEROBIC METABOLISM; AIR POLLUTION; APOPTOSIS; CARDIOVASCULAR SYSTEM; CELL AGING; CENTRAL NERVOUS SYSTEM; CLINICAL EVALUATION; COLLAGEN DEGRADATION; CUTANEOUS PARAMETERS; DERMIS; DIET RESTRICTION; ELASTICITY; ENDOCRINE SYSTEM; ENVIRONMENTAL EXPOSURE; EXTRACELLULAR MATRIX; HEREDITY; HORMONE ACTION; HUMAN; IMMUNE SYSTEM; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SKIN ATROPHY; SKIN DEFECT; SKIN DISEASE; SKIN EXAMINATION; SKIN FIBROBLAST; SKIN FUNCTION; SKIN STRUCTURE; SMOKING; TELOMERE; ULTRAVIOLET RADIATION;

AGING; HUMANS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SKIN; SKIN PHYSIOLOGICAL PHENOMENA;

EID: 51349119574     PISSN: 01425463     EISSN: 14682494     Source Type: Journal    
DOI: 10.1111/j.1468-2494.2008.00454.x     Document Type: Review

References (114)

1. Harman, D. The free radical theory of aging. Antioxid. Redox Signal. 5, 557 561 (2003).
2. Harman, D. Free radical theory of aging: an update: increasing the functional life span. Ann. N. Y. Acad. Sci. 1067, 10 21 (2006).
3. Knight, J. The biochemistry of aging. Adv. Clin. Chem. 35, 1 62 (2000).
4. Radak, Z., Chung, H. Goto, S. Exercise and hormesis: oxidative stress-related adaptation for successful aging. Biogerontology 6, 71 75 (2005).
5. Fisard, M. Ravussin, E. Energy metabolism and oxidative stress: impact on the metabolic syndrome and the aging process. Endocrine 29, 27 32 (2006).
6. Olshansky, S.J. Rattan, S. At the heart of aging: is it metabolic rate or stability? Biogerontology 6, 291 295 (2005).
7. Demetrius, L. Caloric restriction, metabolic rate, and entropy. J. Gerontol. A Biol. Sci. Med. Sci. 59, B902 B915 (2004).
8. Muller, F.L., Lustgarten, M.S., Jang, Y., Richardson, A. Van Remmen, H. Trends in oxidative aging theories. Free Radic. Biol. Med. 43, 477 503 (2007).
9. Cals-Grierson, M.M. Ormerod, A.D. Nitric oxide function in the skin. Nitric Oxide 10, 179 193 (2004).
10. Black, H.S. Pro-oxidant and anti-oxidant mechanism(s) of BHT and beta-carotene in photocarcinogenesis. Front. Biosci. 7, 1044 1055 (2002).
11. Podhaisky, H.P., Riemschneider, S. Wohlrab, W. UV light and oxidative damage of the skin. Pharmazie 57, 30 33 (2002).
12. Squier, T.C. Oxidative stress and protein aggregation during biological aging. Exp. Gerontol. 36, 1539 1550 (2001).
13. Rattan, S.I. Theories of biological aging: genes, proteins, and free radicals. Free Radic. Res. 40, 1230 1238 (2006).
14. Martindale, J.L. Holbrook, N.J. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol., 192, 1 15 (2002).
15. Nelson, K.K. Melendez, J.A. Mitochondrial redox control of matrix metalloproteinases. Free Radic. Biol. Med. 37, 768 784 (2004).
16. Sanz, A., Pamplona, R. Barja, G. Is the mitochondrial free radical theory of aging intact? Antioxid. Redox Signal. 8, 582 599 (2006).
17. Wei, Y. Lee, H. Oxidative stress, mitochondrial DNA mutation an impairment of antioxidant enzymes in aging. Exp. Biol. Med. 227, 671 682 (2002).
18. Lesenefsky, E. Hoppel, C. Oxidative phosphorylation and aging. Ageing Res. Dev. 5, 402 433 (2006).
19. Lindford, N., Schriner, S. Rabinovitch, P. Oxidative damage and aging; spotlight on mitochondria. Cancer Res. 66, 2497 2499 (2006).
20. Melov, S. Mitochondrial oxidative stress. Physiologic consequences and potential role in aging. Ann. N. Y. Acad. Sci. 908, 219 225 (2000).
21. Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614 636 (1965).
22. Orren, D.K. Werner syndrome: molecular insights into the relationships between defective DNA metabolism, genomic instability, cancer and aging. Front. Biosci. 11, 2657 2671 (2006).
23. Crabbe, L., Jauch, A., Naeger, C.M., Holtgreve-Grez, H. Karlseder, J. Telomere dysfunction as a cause of genomic instability in Werner syndrome. Proc. Natl. Acad. Sci. U.S.A. 104, 2205 2210 (2007).
24. Kelland, L. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Clin. Cancer Res. 13, 4960 4963 (2007).
25. Finkel, T., Serrano, M. Blasco, M.A. The common biology of cancer and ageing. Nature 448, 767 774 (2007).
26. Nakagawa, H. Opitz, O.G. Inducing cellular senescence using defined genetic elements. Methods Mol. Biol. 371, 167 178 (2007).
27. Kang, M.K. Park, N.H. Extension of cell life span using exogenous telomerase. Methods Mol. Biol. 371, 151 165 (2007).
28. Karunagaran, D., Joseph, J. Kumar, T.R. Cell growth regulation. Adv. Exp. Med. Biol. 595, 245 268 (2007).
29. Moon, I.K. Jarstfer, M.B. The human telomere and its relationship to human disease, therapy, and tissue engineering. Front. Biosci. 12, 4595 4620 (2007).
30. Jensen, T.G. Cutaneous gene therapy. Ann. Med. 39, 108 115 (2007).
31. Tam, W.L., Ang, Y.S. Lim, B. The molecular basis of ageing in stem cells. Mech. Ageing Dev. 128, 137 148 (2007).
32. Huang, Q., Chen, M., Liang, S. et al. Improving cell therapy-experiments using transplanted telomerase-immortalized cells in immunodeficient mice. Mech. Ageing Dev. 128, 25 30 (2007).
33. Baird, D.M. Telomeres. Exp. Gerontol. 41, 1223 1227 (2006).
34. Siddiqa, A., Cavazos, D.A. Marciniak, R.A. Targeting telomerase. Rejuvenation Res. 9, 378 390 (2006).
35. Stewart, S.A. Weinberg, R.A. Telomeres: cancer to human aging. Ann. Rev. Cell Dev. Biol. 22, 531 557 (2006).
36. Goyns, M.H. Genes, telomeres and mammalian ageing. Mech. Ageing Dev. 123, 791 799 (2002).
37. Mattson, M.P., Fu, W. Zhang, P. Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective. Mech. Ageing Dev. 122, 659 671 (2001).
38. Olovnikov, A.M. Hypothesis: lifespan is regulated by chronomere DNA of the hypothalamus. J. Alzheimers Dis. 11, 241 252 (2007).
39. Flanary, B. The role of microglial cellular senescence in the aging and Alzheimer diseased brain. Rejuvenation Res. 8, 82 85 (2005).
40. Warner, H.R. Is cell death and replacement a factor in aging? Mech. Ageing Dev. 128, 13 16 (2007).
41. Orrenius, S., Gogvadze, V. Zhivotovsky, B. Mitochondrial oxidative stress: implications for cell death. Ann. Rev. Pharmacol. Toxicol. 47, 143 183 (2007).
42. Krajcovicova-Kudlackova, M., Valachovicova, M., Paukova, V. Dusinska, M. Effects of diet and age on oxidative damage products in healthy subjects. Aging Clin. Exp. Res. 19, 75 83 (2007).
43. Pluijm, S.M., Visser, M., Puts, M.T., Dik, M.G., Schalk, B.W. et al. Unhealthy lifestyles during the life course: association with physical decline in late life. JAMA 297, 986 994 (2007).
44. Fontana, L. Klein, S. Aging, adiposity, and calorie restriction. Bioessays 15, 421 426 (1993).
45. Browner, W.S., Kahn, A.J., Ziv, E., Reiner, A.P., Oshima, J. et al. The genetics of human longevity. Am. J. Med. 117, 851 860 (2004).
46. Lehmann, A. Ageing: repair and transcription keep us from premature ageing. Curr. Biol. 20, R550 R551 (2002).
47. Warner, H.R. Longevity genes: from primitive organisms to humans. Mech. Ageing Dev. 26, 235 242 (2005).
48. Kirkwood, T. Ageing: too fast by mistake. Nature 444, 1015 1107 (2006).
49. Puzianowska-Kuznicka, M. Kuznicki, J. Genetic alterations in accelerated ageing syndromes. Do they play a role in natural ageing? Int. J. Biochem. Cell Biol. 37, 947 960 (2005).
50. Thweatt, R. Goldstein, S. Werner syndrome and biological ageing: a molecular genetic hypothesis. Bioessays 15, 421 426 (1993).
51. Nakura, J., Ye, L., Morishima, A., Kohara, K. Miki, T. Helicases and aging. Cell. Mol. Life Sci. 57, 716 730 (2000).
52. Kipling, D., Davis, T., Ostler, E.L. Faragher, R.G. What can progeroid syndromes tell us about human aging? Science 305, 1426 1431 (2004).
53. Kudlow, B.A., Kennedy, B.K. Monnat Jr., R.J. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat. Rev. Mol. Cell Biol. 8, 394 404 (2007).
54. Navarro, C.L., Cau, P. Lévy, N. Molecular bases of progeroid syndromes. Hum. Mol. Genet. 15 Spec No 2 : R151 R161 (2006).
55. Bridger, J.M. Kill, I.R. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterized by hyperproliferation and increased apoptosis. Exp. Gerontol. 39, 717 724 (2004).
56. Pollex, R.L. Hegele, R.A. Hutchinson-Gilford progeria syndrome. Clin. Genet. 66, 375 381 (2004).
57. Rapin, I., Lindenbaum, Y., Dickson, D.W., Kraemer, K.H. Robbins, J.H. Cockayne syndrome and xeroderma pigmentosum. Neurology 55, 1442 1449 (2000).
58. Wenk, J., Brenneisen, P., Meewes, C., Wlaschek, M., Peters, T. et al. UV-induced oxidative stress and photoaging. Curr. Probl. Dermatol. 29, 83 94 (2001).
59. Scaffidi, P. Misteli, T. Lamin A-dependent nuclear defects in human aging. Science 312, 1059 1063 (2006).
60. Fisher, G.J. The pathophysiology of photoaging of the skin. Cutis, 75, 5 9 (2005).
61. Schmuth, M., Watson, R.E., Deplewski, D., Dubrac, S., Zouboulis, C.C. Griffiths, C.E. Nuclear hormone receptors in human skin. Horm. Metab. Res. 39, 96 105 (2007).
62. Reichrath, J., Lehmann, B., Carlberg, C., Varani, J. Zouboulis, C.C. Vitamins as hormones. Horm. Metab. Res. 39, 71 84 (2007).
63. Verdier-Sevrain, S., Bonte, F. Gilchrest, B. Biology of estrogens in skin: implications for skin aging. Exp. Dermatol. 15, 83 94 (2006).
64. Hall, G. Phillips, T.J. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J. Am. Acad. Dermatol. 53, 555 568 (2005).
65. Brincat, M.P., Baron, Y.M. Galea, R. Estrogens and the skin. Climacteric 8, 110 123 (2005).
66. Draelos, Z.D. Topical and oral estrogens revisited for antiaging purposes. Fertil. Steril. 84, 291 292 (2005).
67. Kanda, N Watanabe, S. Regulatory roles of sex hormones in cutaneous biology and immunology. J. Dermatol. Sci. 38, 1 7 (2005).
68. Shin, M.H., Rhie, G.E., Park, C.H., Kim, K.H., Cho, K.H. et al. Modulation of collagen metabolism by the topical application of dehydroepiandrosterone to human skin. J. Invest. Dermatol. 124, 315 323 (2005).
69. Leveque, J.L. Goubanova, E. Influence of age on the lips and perioral skin. Dermatology 208, 307 313 (2004).
70. Irvine, C. Skin failure - a real entity: discussion paper. J. R. Soc. Med. 84, 412 413 (1991).
71. Inamadar, A.C. Palit, A. Acute skin failure: concept, causes, consequences and care. Indian J. Dermatol. Venereol. Leprol. 71, 379 385 (2005).
72. Chung, J.H., Seo, J.Y., Choi, H.R., Lee, M.K., Youn, C.S. et al. Modulation of skin collagen metabolism in aged and photoaged human skin in vivo. J. Invest. Dermatol. 17, 1218 1224 (2001).
73. Sander, C.S., Chang, H., Salzmann, S., Muller, C.S., Ekanayake- Mudiyanselage, S. et al. Photoaging is associated with protein oxidation in human skin in vivo. J. Invest. Dermatol. 118, 618 625 (2002).
74. Oba, A. Edwards, C. Relationships between changes in mechanical properties of the skin, wrinkling, and destruction of dermal collagen fiber bundles caused by photoaging. Skin Res. Technol. 12, 283 288 (2006).
75. Matsumura, Y. Ananthaswamy, H.N. Short-term and long-term cellular and molecular events following UV irradiation of skin: implications for molecular medicine. Expert Rev. Mol. Med. 4, 1 22 (2002).
76. Rattan, S.I. Ali, R.E. Hormetic prevention of molecular damage during cellular aging of human skin fibroblasts and keratinocytes. Ann. N. Y. Acad. Sci. 1100, 424 430 (2007).
77. Demierre, M.F., Brooks, D., Koh, H.K. Geller, A.C. Public knowledge, awareness, and perceptions of the association between skin aging and smoking. J. Am. Acad. Dermatol. 41, 27 30 (1999).
78. Landau, M. Exogenous factors in skin aging. Curr. Probl. Dermatol. 35, 1 13 (2007).
79. Federman, D.G. Kravetz, J.D. Peripheral arterial disease: diagnosis, treatment, and systemic implications. Clin. Dermatol. 25, 93 100 (2007).
80. Aronow, W.S. Peripheral arterial disease. Geriatrics 62, 19 25 (2007).
81. Freiman, A., Bird, G., Metelitsa, A.I., Barankin, B. Lauzon, G.J. Cutaneous effects of smoking. J. Cutan. Med. Surg. 8, 415 423 (2004).
82. Koh, J.S. Cigarette smoking associated with premature facial wrinkling: image analysis of facial skin replicas. Int. J. Dermatol. 41, 21 27 (2002).
83. Kadunce, D.P., Burr, R. Gress, R. Cigarette smoking: risk factor for premature facial wrinkling. Ann. Intern. Med. 114, 840 844 (1991).
84. Ernester, V.L., Grady, D. Miike, R. Facial wrinkling in men and women, by smoking status. Am. J. Public Health 85, 78 82 (1995).
85. Raitio, A., Tuomas, H., Kokkonen, N., Salo, T., Sorsa, T. et al. Levels of matrix metalloproteinase-2, -9 and -8 in the skin, serum and saliva of smokers and non-smokers. Arch. Dermatol. Res. 297, 242 248 (2005).
86. Yin, L., Morita, A. Tsuji, T. Tobacco smoke extract induces age-related changes due to modulation of TGF-beta. Exp. Dermatol. 12 (Suppl. 2 51 56 (2003).
87. Knuutinen, A., Kokkonen, N., Risteli, J., Vahakangas, K., Kallioinen, M. et al. Smoking affects collagen synthesis and extracellular matrix turnover in human skin. Br. J. Dermatol. 146, 588 594 (2002).
88. Yin, L., Morita, A. Tsuji, T. Skin aging induced by ultraviolet exposure and tobacco smoking: evidence from epidemiological and molecular studies. Photodermatol. Photoimmunol. Photomed. 17, 178 183 (2001).
89. Lahmann, C., Bergemann, J., Harrison, G. Young, A.R. Matrix metalloproteinase-1 and skin ageing in smokers. Lancet, 357, 935 936 (2001).
90. Yin, L., Morita, A. Tsuji, T. Alterations of extracellular matrix induced by tobacco smoke extract. Arch. Dermatol. Res. 292, 188 194 (2000).
91. Weinstock, M.A. Progress and prospects on melanoma: the way forward for early detection and reduced mortality. Clin. Cancer Res. 12, 2297s 2300s (2006).
92. Garbe, C. Eigentler, T.K. Diagnosis and treatment of cutaneous melanoma: state of the art 2006. Melanoma Res. 17, 117 1127 (2007).
93. Norval, M., Cullen, A.P., de Gruijl, F.R., Longstreth, J., Takizawa, Y. et al. The effects on human health from stratospheric ozone depletion and its interactions with climate change. Photochem. Photobiol. Sci. 6, 232 251 (2007).
94. Leitenberger, J., Jacobe, H.T. Cruz, P.D. Photoimmunology - illuminating the immune system through photobiology. Semin. Immunopathol. 29, 65 70 (2007).
95. Schade, N., Esser, C. Krutmann, J. Ultraviolet B radiation-induced immunosuppression: molecular mechanisms and cellular alterations. Photochem. Photobiol. Sci. 4, 699 708 (2005).
96. Arnold, S.F. Price, P.S. The LifeLine Group - modeling mixtures resulting from concurrent exposures to multiple sources. Toxicol. Appl. Pharmacol. 223, 121 124 (2007).
97. Van de Sandt, J.J., Dellarco, M. Van Hemmen, J.J. From dermal exposure to internal dose. J. Expo. Sci. Environ. Epidemiol. 17, S38 S47 (2007).
98. Bhatt, V.D. Absorption and evaporation of volatile and potentially hazardous chemicals from human skin. J. Cosmet Sci. 57, 189 190 (2006).
99. Kondo, S. Sauder, D.N. Keratinocyte-derived cytokines and UVB-induced immunosuppression. J. Dermatol. 22, 888 893 (1995).
100. Hart, P.H., Grimbaldeston, M.A. Finlay-Jones, J.J. Sunlight, immunosuppression and skin cancer: role of histamine and mast cells. Clin. Exp. Pharmacol. Physiol. 28, 1 8 (2001).
101. Fisher, G.J. Voorhees, J.J. Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo. J. Investig. Dermatol. Symp. Proc. 3, 61 68 (1998).
102. Pantano, C., Reynaert, N.L., van der Vliet, A. Janssen-Heininger, Y.M. Redox-sensitive kinases of the nuclear factor-kappa-B signaling pathway. Antioxid. Redox Signal. 8, 1791 1806 (2006).
103. Nagai, H., Noguchi, T., Takeda, K. Ichijo, H. Pathophysiological roles of ASK1-MAP kinase signaling pathways. J. Biochem. Mol. Biol. 40, 1 6 (2007).
104. Magnoni, C., Euclidi, E., Benassi, L., Bertazzoni, G., Cossarizza, A. et al. Ultraviolet B radiation induces activation of neutral and acidic sphingomyelinases and ceramide generation in cultured normal human keratinocytes. Toxicol. In Vitro 16, 349 355 (2002).
105. Grether-Beck, S., Bonizzi, G., Schmitt-Brenden, H., Felsner, I., Timmer, A. et al. Non-enzymatic triggering of the ceramide signaling cascade by solar UVA radiation. EMBO J. 19, 5793 5800 (2000).
106. Jiang, Q., Wong, J., Fyrst, H., Saba, J.D. Ames, B.N. Gamma-tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc. Natl. Acad. Sci. U.S.A. 101, 17825 17830 (2004).
107. Ayasolla, K., Khan, M., Singh, A.K. Singh, I. Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E. Free Radic. Biol. Med. 37, 325 338 (2004).
108. Cornwell, D.G. Ma, J. Studies in vitamin E: biochemistry and molecular biology of tocopherol quinones. Vitam. Horm. 76, 99 134 (2007).
109. Azzi, A., Gysin, R., Kempna, P., Munteanu, A., Negis, Y. et al. Vitamin E mediates cell signaling and regulation of gene expression. Ann. N. Y. Acad. Sci. 1031, 86 95 (2004).
110. Hornebeck, W. Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. Pathol. Biol. (Paris) 51, 569 573 (2003).
111. Brenneisen, P., Sies, H. Scharffetter-Kochanek, K. Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events. Ann. N. Y. Acad. Sci. 973, 31 43 (2002).
112. Rittie, L. Fisher, G.J. UV-light-induced signal cascades and skin aging. Ageing Res. Rev. 1, 705 720 (2002).
113. Yan, C. Boyd, D.D. Regulation of matrix metalloproteinase gene expression. J. Cell Physiol. 211, 19 26 (2002).
114. Tian, Y.C., Chen, Y.C., Chang, C.T., Hung, C.C., Wu, M.S. et al. Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. Exp. Cell Res. 313, 2367 2377 (2007).